李军, 孔垂泽. 47例肾盂癌预后因素分析[J]. 中国肿瘤临床, 2004, 31(1): 29-32.
引用本文: 李军, 孔垂泽. 47例肾盂癌预后因素分析[J]. 中国肿瘤临床, 2004, 31(1): 29-32.
Li Jun, Kong Chui ze. Multifactor Prognostic Analysis of Renal Pelvic Cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 31(1): 29-32.
Citation: Li Jun, Kong Chui ze. Multifactor Prognostic Analysis of Renal Pelvic Cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 31(1): 29-32.

47例肾盂癌预后因素分析

Multifactor Prognostic Analysis of Renal Pelvic Cancer

  • 摘要: 目的:提高肾盂癌的治疗效果。方法:采取回顾性研究方法对47例肾盂癌预后因素进行分析。结果:肾盂癌3年生存率为65.9%(31/47),5年生存率为53.1%(24/47)。单纯肾盂癌5年生存率为55%(22/40),同时发生多器官癌5年生存率为26.7%(2/7),P>0.05。肿瘤直径>2.5cm者5年生存率为38.7%(12/31),低于肿瘤直径≤2.5cm者的75%(12/16),P>0.05。IVU重度肾盂肾盏积液或肾不显影者5年生存率为37.9%(11/29),低于无或轻度肾盂肾盏积液者的72.2%(13/18),P>0.05。细胞分级与生存率:5年生存率分别为G1100%(6/6),G265.2%(15/23),G316.7%(3/18),P>0.01。病理分期与生存率:5年生存率分别为T184.6%(11/13),T260.0%(12/20),T3~T47.1%(1/14),P>0.01。G2、T2肿瘤以上采取经腹根治性肾输尿管膀胱部分切除术5年生存率明显高于经腰部肾切除或肾输尿管切除及部分膀胱切除术者,P>0.05。术后再发与非再发膀胱癌者5年生存率无显著性差异,P>0.05。结论:肿瘤细胞分级、病理分期是决定预后的主要因素,采取根治性肾输尿管膀胱部分切除术是提高高分期分级肿瘤疗效的主要方法。

     

    Abstract: Objective : To promote the diagnosis and treatment effect for renal pelvic can-cer. Methods : The prognosis-related factors 47 cases with renal pelvic cancer were retrospectively studied. Results : The overall 3 and 5 year survival rates of renal pelvic cancer were 65.9%(31/ 47) and 53.1% respectively. The 5 year survival rate was 55% in mono-focal renal pelvic cancer and 26.7%(2/7) in coexisting multi-organ carcinoma, P>0.05. The 5 year survival rate was 38.7% (12/31) in the cases with tumor >2.5cm or 75%(12/16) in the cases with tumor ≤2.5cm, P<0.05. The 5 year survival rate was 37.9%(11/29) in the cases with serious hydronephrosis, being significently lower than those of slight hydronephrosis which 5 year survival rate was 72.2%(13/18), P< 0.05. According to pathologic grade, the 5 year survival rate was 100%(6/6) in G1 tumor, 65.2% (15/23) in G2 tumor and 16.7%(3/18) in G3 tumor, P<0.01. According pathologic stage, the 5 year survival rate was 84.6%(11/13) in T1 tumor, 60%(12/20) in T2 tumor and 7.1%(1/14) in T3-T4, P<0.01. With radical nephrouretectomy with partial bladder resection via peritoneum, the 5 year survival rate was significently higher than that with nephrectomy or nephrouretectomy with partial bladder resection in G2 T2 or higher tumor, P<0.05. There was no significent difference be-tween the cases with postoperative occurrence of bladder carcinoma and no-occurrence in the 5 year survival rate, P>0.05. Conclusion : The pathologic grade and stage were the key point for prognosis, radical nephrouretectomy with partial bladder resection was an effective method to im-prove the prognosis of high grade and stage tumor.

     

/

返回文章
返回